Global Innovative Platforms Inc. (GIPL)

Market Cap	118.57M
Revenue (ttm)	n/a
Net Income (ttm)	-354.66K
Shares Out	40.89M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	471
Average Volume	72
Open	1.900
Previous Close	0.140
Day's Range	1.250 - 2.900
52-Week Range	n/a
Beta	6,290.97
RSI	100.00
Earnings Date	Sep 2, 2025

About GIPL

Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath sampler and collection kit. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was incorporated in 2020 and i...

• Industry: Shell Companies
• Sector: Financials
• Founded: 2020
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: GIPL